SCHEMBL23309548

SCHEMBL23309548

O=C(Nc1cccc(Cl)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FADS1 O60427 3/20 0.55
▸ P2RX1 P51575 1/20 0.55
▸ P2RX4 Q99571 1/20 0.55
▸ P2RX7 Q99572 1/20 0.55
▸ AHR P35869 1/20 0.52
▸ RAB9A P51151 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ GRM4 Q14833 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ GRM5 P41594 1/20 0.51
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ MAOB P27338 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309502 0.87 NFKB1 (0.51) FADS1P2RX1P2RX4P2RX7RAB9A
SCHEMBL23309708 0.85 RAB9A (0.52) P2RX1P2RX4P2RX7AHRRAB9A
SCHEMBL23309490 0.84 GAA (0.51) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL23309536 0.84 MEN1 (0.55) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL23309495 0.84 FADS1 (0.56) FADS1RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL23309730 0.82 KMT2A (0.47) P2RX1RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL23309703 0.82 RAB9A (0.51) RAB9ANPC1SMN1; SMN2HDAC6MEN1
SCHEMBL23309568 0.82 P2RX1 (0.59) P2RX1P2RX4P2RX7AHRSMN1; SMN2
SCHEMBL23309531 0.81 MAOB (0.49) FADS1RAB9ANPC1SMN1; SMN2GRM4
SCHEMBL23309546 0.79 NFKB1 (0.50) FADS1P2RX1P2RX4P2RX7RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL FADS1 2452/4885P2RX1 2860/4885P2RX4 3684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback